Cathepsin L is required for endothelial progenitor cell-induced neovascularization. - Test2 - elhamkhani - TriplyDB

Cathepsin L is required for endothelial progenitor cell-induced neovascularization.

Cathepsin L is required for endothelial progenitor cell-induced neovascularization.

http://www.wikidata.org/entity/Q34387265

about

Cathespin H is an Fgf10 target involved in Bmp4 degradation during lung branching morphogenesis Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases The Potential Role of the Proteases Cathepsin D and Cathepsin L in the Progression and Metastasis of Epithelial Ovarian Cancer The crystal structures of two salivary cystatins from the tick Ixodes scapularis and the effect of these inhibitors on the establishment of Borrelia burgdorferi infection in a murine model Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth Deletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancer Multipotent adult progenitor cells sustain function of ischemic limbs in mice.Cathepsin L derived from skeletal muscle cells transfected with bFGF promotes endothelial cell migration.Digit tip regrowth and differential gene expression in MRL/Mpj, DBA/2, and C57BL/6 mice.Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I.The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis.A multistep procedure to prepare pre-vascularized cardiac tissue constructs using adult stem sells, dynamic cell cultures, and porous scaffolds.Palmitate impairs angiogenesis via suppression of cathepsin activity Cystatin C deficiency promotes epidermal dysplasia in K14-HPV16 transgenic mice.P43/pro-EMAPII: a potential biomarker for discriminating traumatic versus ischemic brain injury.Cathepsin L promotes Vascular Intimal Hyperplasia after Arterial Injury Role of stem cells in cardiovascular biology.Chemokines direct endothelial progenitors into tumor neovessels.Targeting stem cell niches and trafficking for cardiovascular therapy Adiponectin pretreatment counteracts the detrimental effect of a diabetic environment on endothelial progenitors.B-cell lymphopoiesis is regulated by cathepsin L.Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis ETS transcription factor ETV2 directly converts human fibroblasts into functional endothelial cells.Cathepsin K-mediated Notch1 activation contributes to neovascularization in response to hypoxia.Relaxin enhances the oncogenic potential of human thyroid carcinoma cells.Molecular pathology in the lungs of severe acute respiratory syndrome patients.CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroids Cysteinyl cathepsins: multifunctional enzymes in cardiovascular disease.Circulating endothelial progenitor cells.The effect of controlled expression of VEGF by transduced myoblasts in a cardiac patch on vascularization in a mouse model of myocardial infarction Antiprotease therapy in cancer: hot or not?Role of cystatins in tumor neovascularization.Secreted proteins as a fundamental source for biomarker discovery.Myeloid cell trafficking and tumor angiogenesis The potential role of aerobic exercise to modulate cardiotoxicity of molecularly targeted cancer therapeutics.Cysteine cathepsins: regulators of antitumour immune response.Genomics and proteomics approaches in understanding tumor angiogenesis.Cathepsins B and D drive hepatic stellate cell proliferation and promote their fibrogenic potential Aging and disease as modifiers of efficacy of cell therapy.Visualizing protease activity in living cells: from two dimensions to four dimensions.

P2860

Q24305496-2AB6A22C-FBEE-43A2-A586-0CE0038585F5 Q24673558-3651993A-704A-4E6A-9633-9E261FBCAAD8 Q26776510-CFCF37C7-300D-465D-A5E2-C3F95CF92CF1 Q27662251-83D4BA6A-78CE-474B-A2A6-23279F46A25B Q28278074-6E44F2FF-DD10-4A3C-8170-33D3CDD56042 Q28505630-0D4AD6B7-D010-415D-8912-4788BF0BF1AB Q30480928-C5EBEA49-3C09-489C-8B57-815F0F61E5EE Q30499994-333ABA1E-AB1A-4BF1-9979-08B867EA7924 Q33277937-B05B5B5E-E5DC-4427-9A60-3EEDC01EDE44 Q33295022-7DB70A03-BBF0-447E-BB46-2259D9D10291 Q33562214-02A9F95C-EE3A-4105-A3B5-A8DCDDE40981 Q33701439-96F620B5-449E-4BA8-96C6-615DCAB7609B Q33702034-A592FAC2-E100-4911-9EC3-AF5BA96E9AD6 Q33749964-690FDFAB-0688-4C83-9CE2-103097D9E2FA Q33772594-2903E2AC-4716-4C37-B191-9050257CBF58 Q33789216-A781CED8-503E-43B7-B726-9B5D9522EB2F Q33809635-AACCC9F7-2FC4-4389-A3D1-1326F169B8C3 Q34212748-96BC08DC-FA0E-4E01-B0B6-0014D4C04BC3 Q34475689-60FE2BE2-945E-483F-8228-04B1CC01FC81 Q34527232-C0F4B160-95E2-421A-9519-E8DB2B64E52B Q34667976-5F60B40D-9FC0-425D-8BD8-3E5E17905454 Q34859485-8EA4B94C-B869-4CA4-8164-5781DFE3CA3D Q34926403-3A004268-B43F-43E6-9D7B-70EEB0535F8D Q35181072-6E3FF430-A033-442E-97A3-2E1B67888D02 Q35221931-EC5234CA-D11C-4F06-83E1-EF8A6AC82028 Q35750156-18322757-CD68-47A5-902C-02260DFFB0E3 Q36177768-3EB7C126-CCB6-4085-9831-81D7CA9F99FD Q36211889-99EB9EDB-F325-433F-9777-84EFF703FD49 Q36270419-965AEC89-ACA3-411C-AFE2-D542EF2E452F Q36374351-8F25FE84-99F0-4F2C-BF9E-5AC53AC8F837 Q36407244-1ECC002A-7C57-4C8C-BF23-22425946C2EF Q36429583-E3A1BCD3-BFD7-4FD4-9633-61CD45C20E3C Q36452973-C1012688-5441-4074-AEAE-558CF286C715 Q36627580-A143B3EB-E3E7-4D98-AA94-33F952B45EAF Q36630478-03CAFC72-22B2-4C7E-848F-24565650C11B Q36708304-68BC5CC2-A320-4516-8911-EEB512F2C930 Q36748498-9F964919-C97A-4584-8FDE-98B1447A81AD Q37161711-09010CD4-9602-4C39-94B2-9C2AA8DC5245 Q37183949-C1D7F4FF-4E4A-43D5-A2BB-B5D5F9F0A856 Q37195574-37EF5AA8-40BE-4CB5-A522-23D0E286BB16

P2860

Cathepsin L is required for endothelial progenitor cell-induced neovascularization.

http://www.wikidata.org/entity/Q34387265

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Cathepsin L is required for endothelial progenitor cell-induced neovascularization.

@ast

Cathepsin L is required for endothelial progenitor cell-induced neovascularization.

@en

Cathepsin L is required for endothelial progenitor cell-induced neovascularization.

@nl

type

label

Cathepsin L is required for endothelial progenitor cell-induced neovascularization.

@ast

Cathepsin L is required for endothelial progenitor cell-induced neovascularization.

@en

Cathepsin L is required for endothelial progenitor cell-induced neovascularization.

@nl

prefLabel

Cathepsin L is required for endothelial progenitor cell-induced neovascularization.

@ast

Cathepsin L is required for endothelial progenitor cell-induced neovascularization.

@en

Cathepsin L is required for endothelial progenitor cell-induced neovascularization.

@nl

P1433

Q34387265-1EA5019E-9577-4830-8775-27C0707659F3

P1476

Q34387265-9C367E0C-F460-4C1B-A473-E65F87A26FC8

P2093

Q34387265-084FDE61-3BCB-48C9-9C0E-857F9FD38FA1

Q34387265-32A173D4-731A-4312-A580-8A51E98C8FAF

Q34387265-3E5BA0DF-D70B-4401-A9ED-1164ADE76BE0

Q34387265-63ABE07F-9BDE-4CAB-A997-4EA3DA522D2B

Q34387265-63AF83C9-8D98-4A01-A76D-3D8E4E0D2240

Q34387265-84B0399E-AD46-487F-BB41-FD741A47C43C

Q34387265-9CE178E3-0627-4DC7-9396-C574465E5850

Q34387265-BCDB35F3-B90A-4187-BEE1-539693261DA4

Q34387265-D0FD2A3E-4B5E-4567-ADFA-98CE2F6B8B0C

Q34387265-F126167F-E6FB-488D-A181-3E5FD784528F

P2888

Q34387265-ACBE3973-0CCC-4B20-8A16-B094E73F4E9E

P304

Q34387265-48DA6903-B907-40E7-8501-B1CD9605F9ED

P31

Q34387265-306DBB85-EF6B-41A2-AA41-B9EBA05C512E

P356

Q34387265-23BBFC4F-E30B-4757-80BA-C600C4D4B660

P407

Q34387265-56CA6A32-9562-45BF-81B3-FB5DCEE4048B

P433

Q34387265-88154C0D-3304-4642-929A-9FB4E577B403

P478

Q34387265-05AB6ED8-4B9F-4CF0-AA80-AB4E178E5E4A

P50

Q34387265-03AA6D58-1165-4AB5-91D0-A8FE1BCCADC6

Q34387265-5C8E0A7A-D1F1-48DE-89D7-B46B568C5EE4

Q34387265-93FF0EBC-F201-4393-BB4B-1AA1BAE2A177

Q34387265-A5B25B48-6D99-471B-8EEB-F59276A0595B

Q34387265-C2253A3D-5821-45E7-ABF3-B5102BE812FC

P577

Q34387265-AAEE23D0-2703-4FB7-96D5-0F8AAE41A906

P5875

Q34387265-5DB56D67-00B4-478A-B6BD-0281F83A4F2D

P6179

Q34387265-B73F12F3-E072-4EF6-9708-877304DFD63D

P698

Q34387265-3EECD390-F49E-4477-81C5-0DF122CA97B4

P921

Q34387265-76227845-4CAB-43E0-BD67-D65BB07C4D6A

Q34387265-948FA045-3D57-430D-AF7E-3980F70C7BE8

P356

P1433

Nature Medicine

P1476

Cathepsin L is required for endothelial progenitor cell-induced neovascularization.

@en

P2093

Christoph Peters

http://www.w3.org/2001/XMLSchema#string

Christopher Heeschen

http://www.w3.org/2001/XMLSchema#string

Emmanouil Chavakis

http://www.w3.org/2001/XMLSchema#string

Ken-ichiro Sasaki

http://www.w3.org/2001/XMLSchema#string

Len A Pennacchio

http://www.w3.org/2001/XMLSchema#string

Mohammad R Farhadi

http://www.w3.org/2001/XMLSchema#string

Nasreddin D Abolmaali

http://www.w3.org/2001/XMLSchema#string

Peter Vajkoczy

http://www.w3.org/2001/XMLSchema#string

Thomas Bruhl

http://www.w3.org/2001/XMLSchema#string

Wolf K Hofmann

http://www.w3.org/2001/XMLSchema#string

P2888

P304

206-213

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM1182

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Stefanie Dimmeler

Thomas Reinheckel

Alexandra Aicher

P577

2005-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8065491

http://www.w3.org/2001/XMLSchema#string

P6179

1010407807

http://www.w3.org/2001/XMLSchema#string

P698

15665831

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization